Table 1.

Baseline clinical and procedural characteristics

	Abciximab alone (n = 254)	Abciximab plus heparin (n = 265)	P value
Age (years)	65 ± 13	65 ± 13	0.963
Male	185 (72%)	198 (75%)	0.526
Current smoker	102 (40%)	96 (37%)	0.428
Hypertension	123 (48%)	108 (41%)	0.137
Cholesterolemia > 200 mg/dl	95 (37%)	110 (41%)	0.267
Diabetes mellitus	36 (14%)	42 (16%)	0.511
Previous myocardial infarction	21 (8%)	32 (13%)	0.152
Anterior infarct location	118 (46%)	112 (42%)	0.379
Cardiogenic shock	7 (3%)	3 (1%)	0.179
Multivessel disease	116 (45%)	115 (43%)	0.660
Preprocedural TIMI grade flow 2–3	58 (23%)	60 (23%)	0.599
Time of ischemia, min	205 ± 124	188 ± 134	0.138
Infarct artery stenting	248 (98%)	260 (98%)	0.481

TIMI Thrombolysis In Myocardial Infarction